Pulmonary hypertension screen — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Transthoracic echocardiography
E. Transthoracic echocardiography is the appropriate next investigation. Progressive exertional dyspnoea, a loud P2 and a markedly reduced TLCO disproportionate to preserved FVC are characteristic warning features for systemic-sclerosis-associated pulmonary arterial hypertension, particularly without crackles suggesting significant interstitial lung disease. Echocardiography estimates pulmonary hypertension probability from tricuspid regurgitation velocity and other right-heart findings and guides referral for definitive right heart catheterisation. NT-proBNP is a useful component of multimodal screening but does not replace cardiac imaging in this symptomatic patient. High-resolution CT assesses interstitial lung disease, while ventilation–perfusion scanning is used principally to exclude chronic thromboembolic disease during the subsequent pulmonary hypertension work-up. Chest radiography is insufficiently sensitive or specific.
Reference: Royal Papworth Hospital NHS Foundation Trust, Pulmonary Vascular Diseases Unit, Information for healthcare professionals—suspected pulmonary hypertension, current page accessed 2026. https://royalpapworth.nhs.uk/our-services/respiratory-services/pvdu/information-healthcare-professionals